2017
DOI: 10.1016/j.joen.2016.10.020
|View full text |Cite
|
Sign up to set email alerts
|

ASH1L Suppresses Matrix Metalloproteinase through Mitogen-activated Protein Kinase Signaling Pathway in Pulpitis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

3
16
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 15 publications
(19 citation statements)
references
References 39 publications
3
16
0
Order By: Relevance
“…3). These results are in accordance with previous studies showing that ASH1L (absent, small, or homeotic 1-like, an H3K4 methyltransferase that can antagonize EZH2) signi cantly upregulate the expression of MMP-1, MMP-2 and MMP-13 through the Mitogen-activated Protein Kinase (MAPK) signaling pathway [16].In the rat experimental pulp infection model, EZH2 decreased the expression of Col-1, but EI1 could not upregulate the expression of Col-1 in rat pulpitis. EI1 could increase the expression of Col-1 in vitro, suggesting that the development of pulpitis is a multifactor regulatory process, and inhibition of EZH2 alone is not enough to promote the repair of collagen bers.…”
Section: Discussionsupporting
confidence: 93%
See 1 more Smart Citation
“…3). These results are in accordance with previous studies showing that ASH1L (absent, small, or homeotic 1-like, an H3K4 methyltransferase that can antagonize EZH2) signi cantly upregulate the expression of MMP-1, MMP-2 and MMP-13 through the Mitogen-activated Protein Kinase (MAPK) signaling pathway [16].In the rat experimental pulp infection model, EZH2 decreased the expression of Col-1, but EI1 could not upregulate the expression of Col-1 in rat pulpitis. EI1 could increase the expression of Col-1 in vitro, suggesting that the development of pulpitis is a multifactor regulatory process, and inhibition of EZH2 alone is not enough to promote the repair of collagen bers.…”
Section: Discussionsupporting
confidence: 93%
“…To gain further insight into the mechanism underlying EZH2-induced cytokine/ chemokine expression in HDPCs, we examined the NF-kB and MAPK pathways, which have been suggested by previous reports to be involved in modulating cytokine/chemokine expression [15,16].EZH2 treatment led to the activation of the MAPK and NF-kB pathways, as demonstrated by phosphorylation of those signaling molecules after 15-45 min of stimulation (Fig.3A).When we treated the HDPC with NF-kB inhibitor (BAY11-7082) or speci c p38(SB203580) inhibitor, the expression of phosphorylation of those signaling molecules were decreased( Fig.3B-C). The EZH2 -mediated induction of MMP-1 MMP-3 MMP-8 and MMP-10 expression decreased signi cantly by treatment with an NF-kB inhibitor (BAY11-7082) or p38(SB203580) inhibitors in 2 hours ( Fig.…”
Section: Ezh2 Promotes Ecm Degradation Via Nf-kb and P38 Signaling Pamentioning
confidence: 99%
“…ASH1L is a mammalian homolog of Drosophila Ash, which activates the expression of multiple genes depending on the activity of the SET domain H3K4 methyltransferase [22,23]. The ASH1L gene is widely expressed in cells in vivo , including CD4 lymphocytes, macrophages, and natural killer (NK) cells [24,25]. Previously reported studies have shown that the expression of ASH1L inhibited interleukin-6 (IL-6) and toll-like receptor (TLR) that triggered the production of tumor necrosis factor (TNF) in a mouse model of sepsis [26].…”
Section: Discussionmentioning
confidence: 99%
“…To gain further insight into the mechanism underlying EZH2-induced cytokine/ chemokine expression in HDPCs, we examined the NF-κB and MAPK pathways, which have been suggested by previous reports to be involved in modulating cytokine/chemokine expression [15,16].EZH2 treatment led to the activation of the MAPK and NF-κB pathways, as demonstrated by phosphorylation of those signaling molecules after 15-45 min of stimulation (Fig.3A).When we treated the HDPC with NF-κB inhibitor (BAY11-7082) or speci c p38(SB203580) inhibitor, the expression of phosphorylation of those signaling molecules were decreased (Fig.3B-C). The EZH2 -mediated induction of MMP-1 MMP-3 MMP-8 and MMP-10 expression decreased signi cantly by treatment with an NF-κB inhibitor (BAY11-7082) or p38(SB203580) inhibitors in 2 hours (Fig.…”
Section: Ezh2 Promotes Ecm Degradation Via Nf-κb and P38 Signaling Pamentioning
confidence: 99%